Skip to content

Clinical trials

Phase 3 Tachycardia, Ventricular trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tachycardia, Ventricular Phase: Phase 3 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20102
20111
20131
20182
20192
20213
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated6
Completed5
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Milestone Pharmaceuticals Inc.4
AstraZeneca1
Ottawa Heart Institute Research Corporation1
Population Health Research Institute1
Texas Cardiac Arrhythmia Research Foundation1
The Methodist Hospital Research Institute1
US Department of Veterans Affairs1
University of California, Los Angeles1
University of Rochester1
Vanderbilt University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tachycardia, Ventricular13
Ventricular Fibrillation3
Atrial Fibrillation2
Death, Sudden, Cardiac2
Tachycardia, Atrioventricular Nodal Reentry2
Arrhythmias, Cardiac1
Cardiomyopathies1
Cardiomyopathy, Dilated1
Death, Sudden1
Heart Failure1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.